IL129482A0 - Method of enhancing the delivery of growth factors - Google Patents

Method of enhancing the delivery of growth factors

Info

Publication number
IL129482A0
IL129482A0 IL12948297A IL12948297A IL129482A0 IL 129482 A0 IL129482 A0 IL 129482A0 IL 12948297 A IL12948297 A IL 12948297A IL 12948297 A IL12948297 A IL 12948297A IL 129482 A0 IL129482 A0 IL 129482A0
Authority
IL
Israel
Prior art keywords
enhancing
delivery
growth factors
diffusion
enhanced
Prior art date
Application number
IL12948297A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL129482A0 publication Critical patent/IL129482A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/185Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
IL12948297A 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors IL129482A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2856696P 1996-10-16 1996-10-16
PCT/US1997/014536 WO1998016242A1 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Publications (1)

Publication Number Publication Date
IL129482A0 true IL129482A0 (en) 2000-02-29

Family

ID=21844162

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12948297A IL129482A0 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Country Status (8)

Country Link
EP (1) EP0938333B1 (de)
JP (1) JP2001502323A (de)
AT (1) ATE258804T1 (de)
AU (1) AU733394B2 (de)
CA (1) CA2269075A1 (de)
DE (1) DE69727491T2 (de)
IL (1) IL129482A0 (de)
WO (1) WO1998016242A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1109572A4 (de) * 1998-09-03 2004-11-24 Neuronz Ltd Neuroprotektion
FR2793684B1 (fr) * 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US7112570B2 (en) 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
GB0303362D0 (en) * 2003-02-13 2003-03-19 Enact Pharma Plc Tissue regeneration
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
GB202303495D0 (en) * 2023-03-09 2023-04-26 Ucl Business Ltd Therapy for charcot-marie-tooth disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
AU3130493A (en) * 1991-11-12 1993-06-15 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding
NZ263102A (en) * 1993-03-19 1997-05-26 Immunex Corp Pharmaceutical compositions comprising a ligand protein such as interleukin-4 and a soluble receptor protein that binds thereto

Also Published As

Publication number Publication date
EP0938333A1 (de) 1999-09-01
DE69727491T2 (de) 2004-12-02
AU4073797A (en) 1998-05-11
ATE258804T1 (de) 2004-02-15
DE69727491D1 (de) 2004-03-11
CA2269075A1 (en) 1998-04-23
EP0938333B1 (de) 2004-02-04
WO1998016242A1 (en) 1998-04-23
JP2001502323A (ja) 2001-02-20
AU733394B2 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
EP1264604A3 (de) Verbesserungen in oder an Kontrastmitteln
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
ATE197549T1 (de) Methoden zur regulation der den magen und darm betreffenden motilitaet
AP9801392A0 (en) Concentrated antibody preparation.
AU2693395A (en) Glial mitogenic factors, their preparation and use
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
ATE140483T1 (de) Natürlicher killerzellen-stimulationsfaktor
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
HUP9900654A3 (en) Preparations stimulating nail growth, process for their preparation and use of them
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
MX9806082A (es) Preparacion farmaceutica combinada de analogos de lhrh y antiestrogenos para el tratamiento de trastornos ginecologicos.
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
IL129482A0 (en) Method of enhancing the delivery of growth factors
EE200000333A (et) Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod
GB9506796D0 (en) Device
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
WO1990013643A3 (en) Glycoprotein hormone receptor molecules
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
RU96111557A (ru) Способ лечения нейросенсорной тугоухости
MXPA01006011A (es) Composicion para tratamiento de quemaduras.
EP0240366A3 (en) Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use
AU1939697A (en) Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
ATE380555T1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng